Bio-Techne (TECH) Shares Outstanding (Weighted Average) (2016 - 2025)
Bio-Techne has reported Shares Outstanding (Weighted Average) over the past 17 years, most recently at $155.8 million for Q4 2025.
- Quarterly results put Shares Outstanding (Weighted Average) at $155.8 million for Q4 2025, down 1.67% from a year ago — trailing twelve months through Dec 2025 was $155.8 million (down 1.67% YoY), and the annual figure for FY2025 was $157.5 million, changed 0.12%.
- Shares Outstanding (Weighted Average) for Q4 2025 was $155.8 million at Bio-Techne, roughly flat from $155.5 million in the prior quarter.
- Over the last five years, Shares Outstanding (Weighted Average) for TECH hit a ceiling of $158.5 million in Q3 2024 and a floor of $38.7 million in Q1 2021.
- Median Shares Outstanding (Weighted Average) over the past 5 years was $157.1 million (2022), compared with a mean of $139.4 million.
- Biggest five-year swings in Shares Outstanding (Weighted Average): skyrocketed 305.71% in 2021 and later dropped 1.93% in 2025.
- Bio-Techne's Shares Outstanding (Weighted Average) stood at $39.3 million in 2021, then surged by 299.42% to $157.0 million in 2022, then grew by 0.33% to $157.5 million in 2023, then grew by 0.6% to $158.5 million in 2024, then decreased by 1.67% to $155.8 million in 2025.
- The last three reported values for Shares Outstanding (Weighted Average) were $155.8 million (Q4 2025), $155.5 million (Q3 2025), and $157.5 million (Q2 2025) per Business Quant data.